Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Intracerebral Transcatheter Laser Photobiomodulation Therapy in the Treatment of Binswanger's Disease and Vascular Parkinsonism: Research and Clinical Experience

AI-generated summary

The authors compared intracerebral transcatheter laser photobiomodulation therapy with conservative treatment in patients with Binswanger's disease and vascular parkinsonism. They report that most laser-treated patients had good or satisfactory clinical results, while few control patients did. The authors describe the treatment as effective, but the abstract does not report sample sizes or follow-up in a way that establishes this.

Who or what was studied
Patients with Binswanger's disease (27) and vascular parkinsonism (62), aged roughly 52 to 81, split into laser-treated test groups and conservatively treated control groups.
Limits stated in the abstract
The abstract reports no randomization, no wavelength or dosing details, and the group sizes and percentages are inconsistent, so the comparison is difficult to interpret.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation therapy, Laser, Photobiomodulation, Control group, Dementia. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Brain & Neurology

A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial

Cognitive, metabolic, and network-level findings are consistent with enhanced mitochondrial efficiency and anti-inflammatory effects. These results support larger, double-blind, multicenter trials to evaluate tPBM as a mitochondria-targeted therapy in early ADRD.

Trial · June 3, 2026 · Rashidi-Ranjbar N et al.